DLL4 and neoplasm: In human tumors, DLL4 expression was thought to be restricted to the tumor vasculature, and its expression appeared to correlate with the clinical outcome in a panel of tumors, such as breast, ovarian, gastric and resected pancreatic tumors 95-98.